Disruption of the ETS2 binding site in Tert promoter or silencing of ETS2 in breast cancer cells has been shown to result in decreased Tert expression and cell proliferation due to the disabling of c-Myc binding to the E-box in Tert promoter [62]. Here, TERT is linked to breast carcinoma.